MediSieve Ltd, a biotech company which has developed an innovative blood filtration device, today announced the participation in the following industry events in September:

40th International Symposium on Intensive Care and Emergency Medicine

Location: Brussels, Belgium
Date: 31^th August – 3^d September, 2021

MedInvest General Life Science Conference

Location: Virtual
Date: 8 – 10^th September, 2021
MedInvest presentation day: 8^th September, 2021

For more upcoming events check “Events” page of the Company’s website at https://www.medisieve.com/News-Events/Events.

About MediSieve

MediSieve is a biotech company, developing “Magnetic Blood Filtration”, a combination of a device and a therapeutic platform of treating blood-borne diseases by removing pathogens, toxins or other targets directly from a patient’s bloodstream. From sepsis to malaria to leukaemia and viral infections, such as COVID-19, MediSieve has the ambition of providing hospitals with a tool to tackle some of mankind’s most serious diseases.

MEDIA CONTACT:

Alina Kagermazova
alina@medisieve.co.uk

INVESTOR AND PARTNERSHIP CONTACT:

George Frodsham
george@medisieve.co.uk

Sort by: Newest First Oldest First Most Popular Most unliked